NED Biosystems
Washington Depot
About NED Biosystems
NED Biosystems Developing proprietary combination cancer therapy. Other IP includes diagnostics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $3.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2018)
- Website: nedbiosystems.com
- Phone: +8608680570
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/ned-biosystems-7468 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.